[Use of teronak for the treatment of obesity with and without diabetes mellitus].
The anorectic drug teronak (made by "Sandoz") was used in the treatment of 73 obese patients, 34 of whom suffered from diabetes mellitus. The drug is well tolerated and had no side effects. Its positive action on the carbohydrate and lipid metabolism was noted during the treatment. The mean loss of weight after a 12-week treatment constituted 10.1 +/- 0.6 kg.
D000273:Adipose Tissue / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D050356:Lipid Metabolism; D008297:Male; D008454:Mazindol / Q000627:therapeutic use*; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy* / Q000378:metabolism
D001786:Blood Glucose; D007211:Indoles; D008454:Mazindol
Primenenie preparata teronak v lechenii bol'nykh ozhireniem i pri sochetanii ozhireniia s sakharnym diabetom.